Organizing Committee Member
Nikolas Tezapsidis
Founder
Neurotez, Inc
USA
Biography
Dr. Tezapsidis is the founder of Neurotez, Inc. and has been the President, Chief Executive Officer and Chairman of the Board of Directors since the company was incorporated in 2005. Nikolaos raised funds through non-dilutive capital sources while building the company, recruiting top talent, maintaining top notch research and development programs and establishing a strong patent portfolio. A few years ago he negotiated a milestone-linked $100 million deal exclusive for China and a partnership with Memtrax for a new memory screening test for Alzheimer’s patients. Currently Neurotez is raising funds for clinical trials testing leptin to treat Alzheimer’s. Recipient of two awards from the Alzheimer’s Association, USA and fellowships from the Wellcome Trust and the Science and Engineering Council, UK. He has several patents issued and pending both in the US and in foreign markets and is the author of more than fifty publications. Dr. Tezapsidis received a Bachelor of Science in Chemistry from the Aristotle University, Greece and completed his Master of Science and Doctor of Philosophy in Biochemistry at the University of Sussex, UK. Nik has been interviewed by The National Herald (http://www.thenationalherald.com/?s=tezapsidis), BioCenturyTV, 1800LiveRadioInterview, and Ellines (https://www.ellines.com/en/category/famous-greeks/ ).
Research Area
Dr. Tezapsidis is the founder of Neurotez, Inc. and has been the President, Chief Executive Officer and Chairman of the Board of Directors since the company was incorporated in 2005. Nikolaos raised funds through non-dilutive capital sources while building the company, recruiting top talent, maintaining top notch research and development programs and establishing a strong patent portfolio. A few years ago he negotiated a milestone-linked $100 million deal exclusive for China and a partnership with Memtrax for a new memory screening test for Alzheimer’s patients. Currently Neurotez is raising funds for clinical trials testing leptin to treat Alzheimer’s. Recipient of two awards from the Alzheimer’s Association, USA and fellowships from the Wellcome Trust and the Science and Engineering Council, UK. He has several patents issued and pending both in the US and in foreign markets and is the author of more than fifty publications. Dr. Tezapsidis received a Bachelor of Science in Chemistry from the Aristotle University, Greece and completed his Master of Science and Doctor of Philosophy in Biochemistry at the University of Sussex, UK. Nik has been interviewed by The National Herald (http://www.thenationalherald.com/?s=tezapsidis), BioCenturyTV, 1800LiveRadioInterview, and Ellines (https://www.ellines.com/en/category/famous-greeks/ ).